Large Molecule Patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| US7709610 | NA | Therapeutic use of anti-CS1 antibodies |
Mar, 2029
(4 years from now) | Active |
Ingredients:
Empliciti contains Elotuzumab as an active ingredient
Activity Alert